Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,1.33 [1.13-1.56],0.000610659567331491,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,2.52 [1.39-4.56],0.0022050116507961,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.47 [0.28-0.8],0.00540250245909901,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.42 [1.1-1.85],0.00825803750292124,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PSAP,Prosaposin,Inverse variance weighted,5,1.88 [1.17-3],0.00865519594025355,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,1.28 [1.06-1.54],0.00934763310215052,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.36 [1.07-1.73],0.0123733956496105,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,0.66 [0.47-0.92],0.015383883334763,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.33 [1.05-1.69],0.0179878623542067,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD302,CD302 antigen,Inverse variance weighted,9,0.65 [0.46-0.94],0.0205166961739899,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.7 [0.52-0.95],0.0207630759354768,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GUCA2A,Guanylin,Inverse variance weighted,9,0.51 [0.29-0.91],0.0219974723749046,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.87 [0.77-0.98],0.0230230603340108,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.57 [0.35-0.93],0.024096423032422,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,2.62 [1.13-6.12],0.025565109647125,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,0.5 [0.27-0.92],0.0268653350620341,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,1.81 [1.07-3.05],0.0270693922617731,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.4 [1.03-1.89],0.0307098236363259,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.79 [0.64-0.98],0.0339948019867346,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.57 [1.03-2.41],0.0360175481576394,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.39 [0.16-0.95],0.0375565185344624,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.58 [0.35-0.97],0.0392273251292088,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,0.86 [0.75-0.99],0.0401177368627368,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.09 [0.01-0.94],0.0442705298631862,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.44 [1.01-2.05],0.0450874695096384,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRG2,Bone marrow proteoglycan,Wald ratio,1,4.01 [1.03-15.63],0.0455429036288723,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.3 [1-1.68],0.0508454155503373,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.79 [0.63-1],0.0530378384863957,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.17 [1-1.38],0.0558201754982177,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.56 [0.31-1.02],0.0562744910108049,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.85 [0.71-1.01],0.0618372167090203,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,1.41 [0.98-2.01],0.0624852046497999,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.85 [0.71-1.01],0.065751229975586,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,2.02 [0.95-4.31],0.0675346737628626,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HBQ1,Hemoglobin subunit theta-1,Inverse variance weighted,14,0.83 [0.68-1.01],0.0691922293420512,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.53 [0.27-1.05],0.0698315242310271,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.85 [0.72-1.02],0.0745422449120557,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.89 [0.79-1.01],0.0762614745286807,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.6 [0.34-1.06],0.0765210502691456,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MATN2,Matrilin-2,Inverse variance weighted,18,1.36 [0.97-1.9],0.0784095606142012,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.42 [0.96-2.1],0.0795505580603095,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.21 [0.03-1.25],0.0853436124614063,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.87 [0.74-1.02],0.0883087819248988,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OGN,Mimecan,Inverse variance weighted,30,1.21 [0.97-1.5],0.0897925684773676,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.77 [0.57-1.04],0.0907724044192935,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCG2,Secretogranin-2,Wald ratio,1,6.76 [0.72-63.85],0.0953548195830653,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,8.44 [0.69-103.75],0.0956481123297374,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.29 [0.96-1.74],0.0966270436108493,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.36 [0.1-1.21],0.0983564971738873,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DSC2,Desmocollin-2,Inverse variance weighted,9,0.75 [0.52-1.06],0.103539796022366,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,2.19 [0.85-5.65],0.105426376438412,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,3.07 [0.76-12.42],0.116380060393434,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,0.79 [0.58-1.06],0.118992141532751,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,0.7 [0.44-1.1],0.119753547148586,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,0.83 [0.66-1.05],0.120202195420344,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.5 [0.2-1.21],0.122203089378187,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,0.56 [0.27-1.17],0.122808431279958,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.14 [0.96-1.35],0.124854386478705,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AMBP,Protein AMBP,Inverse variance weighted,3,0.5 [0.21-1.21],0.125321105065309,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.83 [0.64-1.06],0.130507725523049,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.43 [0.89-2.3],0.134832696259213,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,2.11 [0.79-5.66],0.137210112090405,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.28 [0.05-1.5],0.137371443107947,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.27 [0.93-1.73],0.13746378120258,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OCLN,Occludin,Inverse variance weighted,2,1.84 [0.82-4.12],0.137558427904792,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LGALS9,Galectin-9,Inverse variance weighted,26,0.85 [0.68-1.06],0.155195091255332,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MILR1,Allergin-1,Inverse variance weighted,33,0.92 [0.81-1.03],0.157829946430497,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHGB,Secretogranin-1,Inverse variance weighted,27,0.87 [0.71-1.06],0.159347509661588,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.73 [0.46-1.14],0.161711846298543,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,0.81 [0.61-1.09],0.164423291073883,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.5 [0.84-2.67],0.170736247870554,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.67 [0.38-1.19],0.171106667167063,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.44 [0.14-1.43],0.171248465471304,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PALM2,Paralemmin-2,Inverse variance weighted,8,1.35 [0.88-2.06],0.172383022630426,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF2,Trefoil factor 2,Inverse variance weighted,5,1.64 [0.8-3.33],0.174032385823518,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCHE,Cholinesterase,Inverse variance weighted,30,1.18 [0.92-1.52],0.181752800247615,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,1.62 [0.8-3.29],0.181930148124034,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CST3,Cystatin-C,Inverse variance weighted,10,0.8 [0.57-1.12],0.192415707398275,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.3 [0.87-1.95],0.198865158209637,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.76 [0.49-1.16],0.199812761675861,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,F10,Coagulation factor X,Inverse variance weighted,9,0.89 [0.75-1.06],0.206391214067615,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CFD,Complement factor D,Inverse variance weighted,11,1.24 [0.89-1.75],0.206435869438256,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,1.4 [0.83-2.34],0.206606822304225,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCAN,Neurocan core protein,Inverse variance weighted,3,0.63 [0.31-1.29],0.206680673875946,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.9 [0.7-5.16],0.206750662041476,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CTSL,Cathepsin L1,Wald ratio,1,4.37 [0.44-43.65],0.20926099231234,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C7,Complement component C7,Inverse variance weighted,38,1.08 [0.95-1.23],0.213864661367563,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.29 [0.86-1.94],0.216556650677565,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PENK,Proenkephalin-A,Inverse variance weighted,19,0.83 [0.62-1.11],0.216774659549597,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.39 [0.82-2.35],0.217811851210539,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NECTIN4,Nectin-4,Inverse variance weighted,7,1.22 [0.89-1.67],0.224071948048682,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EDN1,Endothelin-1,Inverse variance weighted,3,0.75 [0.47-1.2],0.22706634555392,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AGRN,Agrin,Inverse variance weighted,17,1.21 [0.88-1.67],0.231484821413047,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,2.01 [0.64-6.31],0.233068700880497,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.26 [0.86-1.86],0.234380015045139,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.13 [0.93-1.37],0.235008813580719,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,0.55 [0.2-1.5],0.23987810735229,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.75 [0.68-4.49],0.242019222921605,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.81 [0.57-1.15],0.24329072445911,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.92 [0.79-1.06],0.254662984556877,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.83 [0.6-1.15],0.260787746839082,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,1.53 [0.73-3.2],0.261148872158375,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.85 [0.63-1.14],0.273129413007639,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.48 [0.13-1.78],0.273998039888536,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.79 [0.51-1.22],0.282171932299713,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD160,CD160 antigen,Inverse variance weighted,11,1.16 [0.88-1.53],0.283612421581723,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MME,Neprilysin,Inverse variance weighted,3,2.01 [0.56-7.27],0.285454263876987,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COLEC12,Collectin-12,Inverse variance weighted,11,0.8 [0.54-1.2],0.285800183513968,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.94 [0.56-6.65],0.293050566573609,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.55 [0.18-1.69],0.293218701277237,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.88 [0.69-1.12],0.293411232135823,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.68 [0.33-1.4],0.295351867631343,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.15 [0.88-1.51],0.300605939722001,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,1.16 [0.88-1.52],0.30109148856219,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1.17 [0.87-1.57],0.302972222702312,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.65 [0.29-1.48],0.305616098873697,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFLAM,Pikachurin,Inverse variance weighted,19,1.1 [0.92-1.31],0.306411597580754,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRELP,Prolargin,Inverse variance weighted,9,1.23 [0.83-1.82],0.312793677345291,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.82 [0.55-1.21],0.314302462787136,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,0.83 [0.58-1.19],0.315097065019536,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1.1 [0.91-1.32],0.319333126940448,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LMNB2,Lamin-B2,Wald ratio,1,0.26 [0.02-3.66],0.321234152456395,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.8 [0.51-1.25],0.329836145975869,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ELN,Elastin,Inverse variance weighted,2,0.5 [0.12-2.02],0.330621557448766,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,APCS,Serum amyloid P-component,Inverse variance weighted,4,0.76 [0.43-1.33],0.331521959041338,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.36 [0.73-2.53],0.335939102929437,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.78 [0.47-1.29],0.336526141756316,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CDH2,Cadherin-2,Inverse variance weighted,3,1.7 [0.57-5.07],0.337278310059674,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.19 [0.83-1.7],0.340912371624171,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.4 [0.7-2.82],0.341105444942584,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRSS8,Prostasin,Inverse variance weighted,5,0.66 [0.28-1.56],0.34253957887702,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.8 [0.5-1.27],0.344008422474664,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,1.37 [0.71-2.66],0.346159292462714,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.14 [0.87-1.5],0.346896458613881,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CALCA,Calcitonin,Inverse variance weighted,5,1.48 [0.65-3.34],0.350933692581964,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.48 [0.1-2.29],0.357968708054569,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.14 [0.86-1.52],0.35930691174221,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SERPINA11,Serpin A11,Inverse variance weighted,31,0.93 [0.79-1.09],0.363569242915523,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,UMOD,Uromodulin,Inverse variance weighted,29,1.07 [0.92-1.25],0.364207893250333,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,F7,Coagulation factor VII,Inverse variance weighted,21,1.14 [0.86-1.51],0.365516482879039,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,XCL1,Lymphotactin,Inverse variance weighted,31,0.93 [0.79-1.09],0.375243837083212,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,1.57 [0.58-4.22],0.375873391968776,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RSPO1,R-spondin-1,Inverse variance weighted,5,1.22 [0.79-1.88],0.377013458147238,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.2 [0.8-1.79],0.382288886809723,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.11 [0.87-1.42],0.392827012987281,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.08 [0.91-1.29],0.397987970149743,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.48 [0.09-2.62],0.398100308109549,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPON2,Spondin-2,Inverse variance weighted,4,1.21 [0.77-1.91],0.405400933040997,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AREG,Amphiregulin,Inverse variance weighted,3,1.34 [0.67-2.66],0.406650263086232,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.61 [0.19-1.96],0.410405121428537,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NECTIN2,Nectin-2,Inverse variance weighted,5,0.86 [0.59-1.24],0.412649211953112,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RSPO3,R-spondin-3,Inverse variance weighted,6,0.8 [0.46-1.38],0.413945126846776,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MUC13,Mucin-13,Inverse variance weighted,9,1.28 [0.71-2.34],0.414325369263322,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.9 [0.7-1.16],0.416155672687946,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.16 [0.81-1.67],0.416568659507204,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LGALS4,Galectin-4,Inverse variance weighted,4,0.74 [0.36-1.53],0.417856636309914,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,1.24 [0.74-2.07],0.418077052553918,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.11 [0.87-1.41],0.420519811001273,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.69 [0.27-1.72],0.421834150669673,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.14 [0.82-1.59],0.423781935896168,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.92 [0.75-1.13],0.432594562362895,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN4,CCN family member 4,Inverse variance weighted,27,0.93 [0.77-1.12],0.43295381654015,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.83 [0.52-1.32],0.43400714380384,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.45 [0.57-3.72],0.437534641912304,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.75 [0.42-7.22],0.439467077879103,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPO,Erythropoietin,Inverse variance weighted,5,0.55 [0.12-2.53],0.440653232001434,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REN,Renin,Inverse variance weighted,4,1.23 [0.72-2.11],0.444443929321584,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.63 [0.46-5.8],0.447630847308003,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPON1,Spondin-1,Inverse variance weighted,21,1.11 [0.85-1.44],0.449686678439781,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,1.2 [0.75-1.93],0.449923371285505,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.78 [0.41-1.48],0.453559014982908,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.51 [0.09-2.95],0.454231458050994,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,THBS2,Thrombospondin-2,Inverse variance weighted,16,1.09 [0.86-1.37],0.469201138750418,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.07 [0.89-1.3],0.469855977795224,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.77 [0.37-1.58],0.471012030681283,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAYN,Layilin,Inverse variance weighted,20,1.12 [0.82-1.52],0.472628181598633,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.35 [0.02-6.28],0.473415765298246,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.9 [0.67-1.21],0.474557921346815,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.23 [0.69-2.19],0.474856760173773,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PVR,Poliovirus receptor,Inverse variance weighted,27,0.94 [0.8-1.11],0.477839774188886,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.52 [0.47-4.89],0.483928621569719,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.71 [0.27-1.88],0.485953033689872,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,1.32 [0.61-2.87],0.486481531181976,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.21 [0.7-2.08],0.488907609737439,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,1.24 [0.68-2.26],0.491041046119735,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.75 [0.35-8.71],0.493481747775046,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PI3,Elafin,Inverse variance weighted,10,1.12 [0.81-1.53],0.50046931055235,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.38 [0.54-3.5],0.500996056627511,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.29 [0.62-2.67],0.502283828405984,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.09 [0.84-1.43],0.505043986247627,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.84 [0.5-1.4],0.507303569792674,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.04 [0.93-1.17],0.509157931567631,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.67 [0.19-2.29],0.518437491389476,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,1.14 [0.76-1.7],0.520634852867144,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BGLAP,Osteocalcin,Inverse variance weighted,2,0.57 [0.1-3.26],0.527890181113991,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.6 [0.37-7.02],0.530190917002487,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.05 [0.9-1.24],0.535774079008733,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.04 [0.91-1.2],0.537083301777177,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.46 [0.04-5.43],0.537202133491201,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD83,CD83 antigen,Inverse variance weighted,5,1.24 [0.63-2.43],0.538259363431936,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCAN,Brevican core protein,Inverse variance weighted,3,1.15 [0.73-1.81],0.538401116372788,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLK11,Kallikrein-11,Inverse variance weighted,6,1.07 [0.86-1.34],0.541855208975814,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.79 [0.36-1.7],0.542941381463515,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL15,Interleukin-15,Wald ratio,1,0.07 [0-377.41],0.545247812755734,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.81 [0.4-1.62],0.54564236158779,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.1 [0.8-1.52],0.546855290734629,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.9 [0.63-1.28],0.551764043656276,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.8 [0.26-12.46],0.553011715179609,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.11 [0.79-1.56],0.556514209462176,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.1 [0.79-1.55],0.561570201487619,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.47 [0.12-52.15],0.56190770082233,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.93 [0.73-1.18],0.562351165341734,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.88 [0.57-1.36],0.56289489325076,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.15 [0.71-1.86],0.566675202013375,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.07 [0.86-1.32],0.566762210443911,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.89 [0.6-1.32],0.567744163937122,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,1.25 [0.58-2.69],0.569067252421649,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.92 [0.7-1.22],0.571792114457054,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.8 [0.37-1.74],0.576407441355772,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.13 [0.74-1.71],0.577443045799372,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.1 [0.79-1.52],0.577789122734134,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.93 [0.73-1.19],0.579647301993578,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.9 [0.61-1.32],0.588799266437381,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.22 [0.59-2.5],0.594166944428842,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.92 [0.68-1.25],0.595729286377098,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.78 [0.3-1.98],0.598226865511483,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.1 [0.78-1.55],0.59836166395262,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1.07 [0.83-1.39],0.599588996349083,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBP2,Retinol-binding protein 2,Wald ratio,1,0.63 [0.11-3.59],0.600742922814049,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NFASC,Neurofascin,Inverse variance weighted,15,1.08 [0.8-1.46],0.602916285989354,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPPC,C-type natriuretic peptide,Wald ratio,1,0.51 [0.04-6.61],0.60940321442635,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.85 [0.45-1.59],0.609551772289568,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,0.91 [0.65-1.29],0.61320980471459,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.91 [0.63-1.32],0.618971476925925,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,1.2 [0.58-2.5],0.624142056030788,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.56 [0.05-5.9],0.625514241258877,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,0.93 [0.7-1.24],0.630747805193143,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GRN,Progranulin,Inverse variance weighted,7,1.09 [0.76-1.56],0.631550983949586,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,0.92 [0.65-1.31],0.641604685316971,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.87 [0.47-1.59],0.647659275630884,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FBLN2,Fibulin-2,Inverse variance weighted,11,1.08 [0.77-1.52],0.658662728046373,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.8 [0.29-2.19],0.659571126217911,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.05 [0.84-1.31],0.670219553098664,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.53 [0.21-11.1],0.672349218086845,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PTN,Pleiotrophin,Inverse variance weighted,4,1.21 [0.49-2.97],0.676557489890354,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.56 [0.04-8.75],0.6771418567717,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,0.86 [0.41-1.79],0.678553575714869,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.86 [0.42-1.78],0.681853445344091,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.95 [0.72-1.24],0.682429058506205,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RETN,Resistin,Inverse variance weighted,9,0.96 [0.77-1.19],0.682940461907095,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,1.82 [0.1-33],0.68593388349493,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.06 [0.79-1.44],0.686095468528285,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,0.72 [0.15-3.53],0.688583941473912,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.04 [0.86-1.25],0.689379240530817,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.14 [0.61-2.13],0.689729601696738,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SEPTIN8,Septin-8,Inverse variance weighted,2,1.32 [0.34-5.16],0.694114845536025,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1.02 [0.92-1.13],0.694127966640897,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.1 [0.69-1.75],0.699920783924896,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.84 [0.33-2.09],0.700186514389208,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.03 [0.89-1.18],0.702466517203244,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NRP1,Neuropilin-1,Inverse variance weighted,12,1.06 [0.79-1.42],0.703055280720188,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.88 [0.45-1.73],0.706474197319604,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.07 [0.75-1.53],0.707109221677501,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.93 [0.61-1.4],0.716334807221299,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.96 [0.75-1.22],0.718771885872508,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HSPB6,Heat shock protein beta-6,Wald ratio,1,1.63 [0.11-23.13],0.719705409895494,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.93 [0.63-1.38],0.719984091109113,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.85 [0.35-2.08],0.724446736930015,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.03 [0.85-1.25],0.725401120622249,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.12 [0.57-2.19],0.740385766865893,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.45 [0-52.42],0.740789362353458,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.13 [0.51-2.55],0.759844696599997,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSTB,Cystatin-B,Inverse variance weighted,28,1.04 [0.83-1.29],0.760485124219635,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1.07 [0.68-1.7],0.763543545559178,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.05 [0.76-1.44],0.767648635782966,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.89 [0.4-1.97],0.770815354939428,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,1.05 [0.74-1.5],0.77540512192297,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,0.98 [0.83-1.15],0.776406592940247,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.05 [0.76-1.43],0.776960281443091,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,1.1 [0.57-2.13],0.782008165707371,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [0.87-1.2],0.784631317152564,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.02 [0.88-1.19],0.78766799855381,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,0.92 [0.49-1.73],0.791223558158812,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.97 [0.75-1.25],0.801807930291885,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.03 [0.83-1.27],0.802358574184861,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SERPIND1,Heparin cofactor 2,Wald ratio,1,0.86 [0.25-2.9],0.802783887574717,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.91 [0.43-1.92],0.80413345447721,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.03 [0.83-1.27],0.806109789556162,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNC,Tenascin,Inverse variance weighted,12,1.06 [0.66-1.69],0.80793659047609,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SDC1,Syndecan-1,Inverse variance weighted,2,0.91 [0.43-1.95],0.809842211925857,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.1 [0.5-2.43],0.811677392948391,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.02 [0.87-1.2],0.817466976018401,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.05 [0.7-1.55],0.822560840242199,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLK4,Kallikrein-4,Inverse variance weighted,17,0.97 [0.77-1.23],0.825786999815835,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,1.03 [0.78-1.36],0.826483287872942,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.03 [0.78-1.37],0.827452200236911,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.1 [0.45-2.68],0.830366498748259,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.96 [0.64-1.45],0.840022942490124,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.02 [0.83-1.26],0.846537522852125,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.11 [0.39-3.11],0.84722096295503,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN5,CCN family member 5,Inverse variance weighted,8,0.92 [0.4-2.12],0.847459368047197,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SDC4,Syndecan-4,Inverse variance weighted,8,1.05 [0.65-1.68],0.851489629964315,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,0.97 [0.71-1.33],0.8533723909891,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHGA,Chromogranin-A,Inverse variance weighted,3,1.08 [0.45-2.61],0.855806565564037,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.97 [0.73-1.3],0.859561456238544,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,0.94 [0.49-1.81],0.860127457427875,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD27,CD27 antigen,Inverse variance weighted,9,1.03 [0.75-1.4],0.860173237113631,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.88 [0.21-3.62],0.861638685991081,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VWC2,Brorin,Inverse variance weighted,22,0.97 [0.73-1.3],0.861686003285837,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PGF,Placenta growth factor,Inverse variance weighted,2,1.27 [0.09-18.75],0.862419490678069,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MMP7,Matrilysin,Inverse variance weighted,13,0.96 [0.64-1.46],0.862482168114281,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MDK,Midkine,Inverse variance weighted,4,0.94 [0.47-1.88],0.863571859290522,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [0.84-1.23],0.867298398605468,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.02 [0.82-1.26],0.868035725199174,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.02 [0.82-1.26],0.870331046992554,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.06 [0.52-2.17],0.871696173941866,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.03 [0.76-1.39],0.87176710465576,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.06 [0.54-2.05],0.873887443233914,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.98 [0.73-1.3],0.875583845020311,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.16 [0.18-7.31],0.878068421790422,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.99 [0.82-1.19],0.880582602219112,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.02 [0.81-1.28],0.891620142841693,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,1.04 [0.58-1.88],0.896824430570654,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.03 [0.68-1.56],0.899786107002158,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.03 [0.61-1.75],0.904643091602307,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.96 [0.52-1.79],0.905609945456372,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SNCG,Gamma-synuclein,Inverse variance weighted,36,1.01 [0.84-1.21],0.905676343872958,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.91 [0.18-4.55],0.906943934086045,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.99 [0.8-1.22],0.91636499495201,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.19 [0.05-28.82],0.916647617077656,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.98 [0.64-1.5],0.929841490616005,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,0.99 [0.69-1.41],0.934570049488565,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.97 [0.47-2],0.934662919071924,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.85-1.2],0.936037440067864,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL19,Interleukin-19,Inverse variance weighted,11,0.99 [0.72-1.35],0.93691626001463,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.99 [0.65-1.49],0.944428833669518,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPP1,Osteopontin,Inverse variance weighted,8,1.03 [0.5-2.12],0.944431443319526,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.99 [0.7-1.39],0.9458724939733,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LCN15,Lipocalin-15,Inverse variance weighted,20,0.99 [0.83-1.19],0.949822875589588,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.99 [0.71-1.38],0.95197936408196,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.96 [0.23-4],0.95763581118092,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLXNB2,Plexin-B2,Inverse variance weighted,27,1 [0.89-1.13],0.957963169014883,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.98 [0.54-1.8],0.95840962458647,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL17C,Interleukin-17C,Inverse variance weighted,3,1.03 [0.35-3],0.961533491969148,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,1.01 [0.77-1.32],0.962855997551912,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.01 [0.53-1.95],0.970735027630032,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1 [0.78-1.27],0.971096309344159,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN3,CCN family member 3,Inverse variance weighted,19,1 [0.72-1.38],0.980272231381763,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.02 [0.28-3.63],0.981145043688002,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.03 [0.06-16.62],0.983664047040997,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASET2,Ribonuclease T2,Inverse variance weighted,14,1 [0.79-1.26],0.990305705548433,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.99 [0.3-3.28],0.992034204827616,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,1 [0.63-1.59],0.995752588162842,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1 [0.34-2.92],0.996473124523187,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1 [0.59-1.68],0.997916260529537,cis
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,2.22 [1.35-3.66],0.0016998292167906,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MDK,Midkine,Inverse variance weighted,14,0.46 [0.26-0.8],0.00616818822178157,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL6,Interleukin-6,Inverse variance weighted,6,1.86 [1.18-2.94],0.00777484015500845,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,3.42 [1.38-8.47],0.0078523258921162,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.39 [0.19-0.8],0.010758603006396,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,XG,Glycoprotein Xg,Inverse variance weighted,2,0.1 [0.02-0.59],0.0108814009796708,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,21.1 [1.94-230.15],0.0123624366737472,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OGN,Mimecan,Inverse variance weighted,37,1.3 [1.05-1.61],0.0164194885564847,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,2.12 [1.14-3.93],0.0175783098314362,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.36 [0.15-0.84],0.0187616536474103,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PSAP,Prosaposin,Inverse variance weighted,13,1.51 [1.07-2.14],0.0192756794192533,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.42 [1.06-1.9],0.019908901194832,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.4 [0.18-0.87],0.0213300166001709,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.89 [1.1-3.23],0.0213501019190268,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.88 [1.08-3.27],0.0249414104335589,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.22 [0.06-0.85],0.0279988930821702,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.67 [1.06-2.65],0.0286124039117659,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COLEC12,Collectin-12,Inverse variance weighted,3,5.01 [1.14-22.14],0.0333645889186565,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.52 [0.28-0.96],0.0368011897200957,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.33 [0.11-0.94],0.0373171084480596,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.62 [1.03-2.56],0.0373505184110225,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD160,CD160 antigen,Inverse variance weighted,24,1.49 [1-2.22],0.0501415390278631,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.61 [0.37-1.01],0.0538081319531048,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRELP,Prolargin,Inverse variance weighted,5,3.78 [0.95-14.97],0.058290476967565,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.28 [0.08-1.05],0.0585006544000949,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.74 [0.98-3.11],0.0605804747447447,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,0.81 [0.64-1.01],0.0618702998826299,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.62 [0.38-1.03],0.0625038519920545,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.48 [0.22-1.05],0.0650423895835471,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.55 [0.29-1.04],0.067895472878842,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.62 [0.96-2.73],0.0712063748805878,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,1.45 [0.96-2.17],0.0762560521128738,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RETN,Resistin,Inverse variance weighted,19,1.56 [0.95-2.55],0.0787064274351883,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LGALS9,Galectin-9,Inverse variance weighted,36,0.83 [0.67-1.03],0.0849971221779841,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.67 [0.42-1.06],0.0873169804870985,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HGF,Hepatocyte growth factor,Inverse variance weighted,5,2.37 [0.88-6.42],0.0889233161036848,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,1.55 [0.94-2.57],0.089032928283014,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,0.49 [0.21-1.14],0.0972130386029103,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.85 [0.71-1.03],0.0985920492938997,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GAST,Gastrin,Inverse variance weighted,9,1.73 [0.9-3.32],0.099572177869365,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MME,Neprilysin,Inverse variance weighted,46,0.82 [0.65-1.04],0.101525221552695,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,2.67 [0.82-8.67],0.10322581033161,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RSPO3,R-spondin-3,Inverse variance weighted,5,0.47 [0.19-1.17],0.104037957776074,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE4,Ribonuclease 4,Inverse variance weighted,2,3.65 [0.77-17.44],0.104167105527343,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD302,CD302 antigen,Inverse variance weighted,11,1.64 [0.89-2.99],0.109819228936349,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.26 [0.95-1.67],0.113875837869049,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,2.17 [0.83-5.69],0.115258141111689,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN4,CCN family member 4,Inverse variance weighted,29,0.83 [0.66-1.05],0.116244887228922,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,7.76 [0.58-103.01],0.120528332781509,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.61 [0.87-2.99],0.127640050947199,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.43 [0.9-2.26],0.128984912463655,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LGALS4,Galectin-4,Inverse variance weighted,15,0.8 [0.59-1.07],0.135201732334427,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,2.26 [0.77-6.61],0.136218508555326,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD83,CD83 antigen,Inverse variance weighted,14,0.67 [0.39-1.14],0.141269682352996,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.7 [0.84-3.45],0.143646745112781,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NFASC,Neurofascin,Inverse variance weighted,6,2.11 [0.77-5.76],0.143862170603187,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,3.3 [0.66-16.63],0.14775389594169,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.58 [0.27-1.22],0.149367650837462,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RSPO1,R-spondin-1,Inverse variance weighted,8,0.56 [0.25-1.23],0.149419727121848,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,2.06 [0.76-5.58],0.153744869623438,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.29 [0.05-1.64],0.161779252335445,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.74 [0.49-1.13],0.16260228851039,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,0.7 [0.42-1.16],0.163010748288036,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.44 [0.14-1.4],0.164807518996228,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AMBP,Protein AMBP,Inverse variance weighted,5,0.57 [0.26-1.26],0.165072809928525,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.92 [0.81-1.04],0.167949053789225,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,2.44 [0.67-8.91],0.175330413627352,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.79 [0.77-4.19],0.179485274757258,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.29 [0.88-1.87],0.190578267191355,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SDC1,Syndecan-1,Inverse variance weighted,12,0.71 [0.41-1.2],0.19772401192994,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NECTIN2,Nectin-2,Inverse variance weighted,3,0.33 [0.06-1.8],0.198966467208274,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.18 [0.01-2.49],0.202950902065776,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,0.87 [0.7-1.08],0.203333555198227,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.75 [0.73-4.17],0.206226667632638,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCG2,Secretogranin-2,Inverse variance weighted,2,0.43 [0.11-1.62],0.212246330305658,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.44 [0.81-2.57],0.215525997359676,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AREG,Amphiregulin,Inverse variance weighted,5,2.12 [0.64-6.99],0.216539372089868,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.99 [0.67-5.9],0.217076682730594,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,0.67 [0.36-1.27],0.218755224995568,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.98 [0.66-5.95],0.221771169300887,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MILR1,Allergin-1,Inverse variance weighted,43,0.92 [0.8-1.05],0.224443864219057,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.55 [0.76-3.18],0.228462311656056,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.44 [0.12-1.67],0.229399850846388,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.81 [0.69-4.81],0.23055800573999,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NRP1,Neuropilin-1,Inverse variance weighted,14,0.71 [0.41-1.24],0.230915437960492,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.53 [0.75-3.14],0.242570678574352,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.61 [0.26-1.41],0.246266321423352,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,0.7 [0.38-1.3],0.259042929084224,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,0.64 [0.29-1.4],0.261384845890632,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PGF,Placenta growth factor,Inverse variance weighted,5,1.61 [0.69-3.77],0.267679366419182,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,UMOD,Uromodulin,Inverse variance weighted,34,1.27 [0.83-1.95],0.268601488617857,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,2.62 [0.47-14.67],0.274395831017625,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD99,CD99 antigen,Inverse variance weighted,4,0.62 [0.26-1.47],0.276460564461728,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.67 [0.32-1.39],0.277172823123123,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFLAM,Pikachurin,Wald ratio,1,0.16 [0.01-4.3],0.277251862533571,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C7,Complement component C7,Inverse variance weighted,26,1.12 [0.91-1.39],0.277983003469967,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CTSL,Cathepsin L1,Inverse variance weighted,29,1.22 [0.85-1.76],0.280692110236692,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.61 [0.68-3.81],0.281469699389252,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPON2,Spondin-2,Inverse variance weighted,3,2.18 [0.52-9.11],0.284438652517367,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,1.21 [0.85-1.73],0.285250415087274,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.24 [0.83-1.85],0.285256998012823,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.61 [0.24-1.52],0.288811029879237,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.26 [0.82-1.95],0.291432008933798,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.13 [0.9-1.42],0.293830873878612,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,2.08 [0.53-8.23],0.295427019462441,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,3.43 [0.34-34.79],0.297773655342058,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.54 [0.68-3.45],0.299399905639208,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,F7,Coagulation factor VII,Inverse variance weighted,10,1.4 [0.73-2.69],0.304191519028478,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.74 [0.6-5.04],0.304443412338165,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.81 [0.55-1.21],0.307059542818338,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.28 [0.79-2.08],0.308355798393337,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LCN15,Lipocalin-15,Inverse variance weighted,22,1.09 [0.92-1.3],0.309934222606191,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.25 [0.02-3.62],0.31002523486067,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MATN2,Matrilin-2,Inverse variance weighted,28,1.11 [0.91-1.35],0.312987446687106,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.76 [0.44-1.3],0.313829464405421,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD27,CD27 antigen,Inverse variance weighted,9,0.61 [0.24-1.59],0.313956339600378,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.39 [0.06-2.46],0.319814617417215,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1.38 [0.73-2.61],0.320010566704099,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.52 [0.14-1.91],0.325406004247392,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.35 [0.04-2.81],0.326225639862653,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,F10,Coagulation factor X,Inverse variance weighted,11,1.25 [0.8-1.96],0.328077372235038,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,0.76 [0.44-1.31],0.328308815232452,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,WNT9A,Protein Wnt-9a,Wald ratio,1,4.39 [0.22-86.22],0.329893161274262,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.41 [0.07-2.47],0.330657519768368,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NECTIN4,Nectin-4,Inverse variance weighted,4,2.26 [0.44-11.68],0.332200262021957,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,3.15 [0.31-32.16],0.332732488054635,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.55 [0.16-1.85],0.334278673344343,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,0.62 [0.23-1.66],0.339281647151273,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,2.24 [0.43-11.82],0.341308644698306,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MUC13,Mucin-13,Inverse variance weighted,3,2.88 [0.33-25.43],0.341552056507851,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.73 [0.55-5.42],0.349729074541775,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.29 [0.75-2.21],0.350597858042041,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.9 [0.73-1.12],0.352148988968855,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPP1,Osteopontin,Inverse variance weighted,13,0.74 [0.39-1.41],0.353953324437418,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DSC2,Desmocollin-2,Inverse variance weighted,16,0.86 [0.63-1.18],0.359945428321302,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL17C,Interleukin-17C,Inverse variance weighted,5,0.62 [0.22-1.74],0.360578539200552,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.81 [0.52-1.27],0.361886651056532,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.44 [0.07-2.61],0.368219182868834,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VWC2,Brorin,Inverse variance weighted,12,0.73 [0.37-1.45],0.369855826684242,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,0.78 [0.45-1.36],0.380740961539638,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL15,Interleukin-15,Inverse variance weighted,35,1.18 [0.81-1.73],0.38096327971274,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.09 [0.89-1.33],0.383189085243692,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GDF15,Growth/differentiation factor 15,Wald ratio,1,4 [0.18-90.54],0.384190527651363,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,0.46 [0.08-2.62],0.384560314913335,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.74 [0.37-1.47],0.385165413165753,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PALM2,Paralemmin-2,Inverse variance weighted,9,1.25 [0.76-2.06],0.385886167770001,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.18 [0.81-1.73],0.387100889222863,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SDC4,Syndecan-4,Inverse variance weighted,35,1.14 [0.85-1.53],0.388858068893832,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.65 [0.25-1.73],0.39122241178858,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.69 [0.29-1.62],0.392250544549779,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.48 [0.6-3.65],0.395901910789042,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,2 [0.4-9.99],0.396181327692561,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.18 [0.8-1.75],0.396742339247934,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CALCA,Calcitonin,Inverse variance weighted,13,0.75 [0.39-1.45],0.39698537835659,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,1.1 [0.88-1.37],0.397594755536108,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ELN,Elastin,Inverse variance weighted,10,0.72 [0.34-1.55],0.40801887579655,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.79 [0.45-1.39],0.412074951768548,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.38 [0.62-3.09],0.428255862835028,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,0.8 [0.46-1.39],0.42967636990923,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.75 [0.36-1.54],0.430544899509919,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HBQ1,Hemoglobin subunit theta-1,Wald ratio,1,0.38 [0.04-4.16],0.431371408781265,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.34 [0.64-2.8],0.432036112643448,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.66 [0.23-1.88],0.438219900239494,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.33 [0.64-2.75],0.441912257600748,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.11 [0.85-1.46],0.443254488649726,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.4 [0.59-3.28],0.445234454956114,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.75 [0.35-1.58],0.448273240830254,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.4 [0.59-3.32],0.448495953216825,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.57 [0.14-2.42],0.448639250284626,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF8,SLAM family member 8,Inverse variance weighted,2,2.16 [0.29-15.89],0.450964599488753,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CST3,Cystatin-C,Inverse variance weighted,3,0.44 [0.05-3.77],0.453051801445877,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.51 [0.09-2.95],0.454231458050994,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.24 [0.7-2.2],0.461316767004524,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.49 [0.07-3.3],0.465264424186932,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.15 [0.79-1.66],0.465509931554016,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.52 [0.09-3.08],0.471651131868193,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.44 [0.53-3.92],0.478032041236306,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,0.77 [0.38-1.58],0.481831432046734,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CDH2,Cadherin-2,Inverse variance weighted,21,1.15 [0.77-1.72],0.483531029199557,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.29 [0.63-2.65],0.484131216096297,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.52 [0.08-3.26],0.487170142492935,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LMNB2,Lamin-B2,Inverse variance weighted,8,1.4 [0.53-3.7],0.492355499459353,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.61 [0.15-2.48],0.493199094726285,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CFD,Complement factor D,Wald ratio,1,0.46 [0.05-4.28],0.494778449616609,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.31 [0.6-2.83],0.494806660092133,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,0.84 [0.51-1.38],0.498069993828261,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SEPTIN8,Septin-8,Inverse variance weighted,4,1.62 [0.4-6.57],0.498799498112315,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.84 [0.5-1.4],0.507303569792674,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.06 [0.89-1.27],0.508780409575289,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,0.9 [0.64-1.25],0.514132945683523,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1.1 [0.82-1.47],0.519448503150582,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.81 [0.42-1.56],0.525498787534202,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.79 [0.37-1.66],0.526074609193485,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.81 [0.41-1.57],0.527975749764241,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.25 [0.62-2.49],0.532087040047481,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.81 [0.41-1.58],0.535016723165673,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.86 [0.54-1.38],0.538716520310336,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.33 [0.53-3.31],0.546524399191733,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.45 [0.43-4.81],0.5485959505254,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,0.9 [0.63-1.28],0.550819034196008,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.81 [0.41-1.6],0.551559853125746,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.32 [0.52-3.35],0.554355590750739,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.13 [0.75-1.7],0.557023864263679,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.43 [0.44-4.67],0.557776311068978,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,1.39 [0.46-4.2],0.560045256826894,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SERPINA11,Serpin A11,Inverse variance weighted,14,0.79 [0.36-1.73],0.561984544159353,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.73 [0.26-2.11],0.565426178873,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.16 [0.69-1.95],0.573643095296755,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.63 [0.13-3.17],0.574238586926047,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.59 [0.09-3.78],0.578448460802589,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,2.9 [0.07-126.81],0.580081822606621,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.28 [0.53-3.08],0.583267531328681,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.81 [0.37-1.75],0.584114336950538,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN5,CCN family member 5,Inverse variance weighted,12,1.1 [0.77-1.58],0.592746905456854,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,0.83 [0.42-1.63],0.593227927695462,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.53 [0.32-7.28],0.593932344758913,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.06 [0.85-1.32],0.595482598167189,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,1.41 [0.4-4.99],0.596717575259093,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.88 [0.56-1.4],0.600677154418902,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.94 [0.76-1.17],0.600747828838895,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.29 [0.49-3.38],0.600877782739191,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCHE,Cholinesterase,Inverse variance weighted,38,1.08 [0.81-1.44],0.602292416821784,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.25 [0.54-2.88],0.604548298455247,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.77 [0.28-2.1],0.604647718625058,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSTB,Cystatin-B,Inverse variance weighted,23,1.07 [0.84-1.36],0.605205516383322,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.76 [0.26-2.17],0.606632340185309,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHGA,Chromogranin-A,Inverse variance weighted,5,0.78 [0.29-2.06],0.615451815540389,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.22 [0.56-2.68],0.615642493537295,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SPON1,Spondin-1,Inverse variance weighted,4,0.71 [0.18-2.74],0.620511598228416,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.83 [0.4-1.73],0.622636153507707,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.9 [0.58-1.39],0.623078493108012,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.91 [0.61-1.35],0.629985928422806,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,0.73 [0.21-2.62],0.634654815291956,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.71 [0.17-2.92],0.639067987043236,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,0.91 [0.62-1.34],0.64136361140455,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,0.8 [0.31-2.07],0.642819098585719,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.89 [0.55-1.46],0.645272271223311,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.12 [0.68-1.84],0.649816044695915,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.63 [0.09-4.59],0.650146280020576,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.72 [0.16-3.15],0.658546771319131,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.96 [0.79-1.16],0.661845390832425,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,1.18 [0.56-2.46],0.662229494407821,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PI3,Elafin,Inverse variance weighted,18,1.07 [0.8-1.43],0.662711033578045,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.19 [0.54-2.61],0.663283967328103,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL19,Interleukin-19,Inverse variance weighted,10,1.09 [0.74-1.6],0.667574458746935,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.66 [0.1-4.45],0.668163389468681,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.92 [0.63-1.34],0.674118067820448,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.14 [0.62-2.11],0.675120012091567,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.54 [0.2-11.62],0.676882422207831,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,1.13 [0.63-2.04],0.677033279583869,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCAN,Neurocan core protein,Inverse variance weighted,19,0.91 [0.57-1.44],0.678754042286515,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.49 [0.22-10.23],0.683083071116829,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.9 [0.53-1.53],0.683887513597254,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.08 [0.75-1.54],0.688773114390612,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.24 [0.44-3.5],0.690267273526957,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.03 [0.88-1.21],0.691315233788429,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.81 [0.29-2.29],0.695281669506272,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PTN,Pleiotrophin,Inverse variance weighted,3,0.78 [0.23-2.7],0.695825577878678,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.14 [0.59-2.18],0.698399330804803,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.64 [0.06-6.43],0.705043362606316,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.17 [0.53-2.57],0.705101546801808,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,0.92 [0.6-1.42],0.70544366729311,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.27 [0.36-4.44],0.706717131719228,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.76 [0.19-3.11],0.707121406141596,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.94 [0.69-1.29],0.717681644753059,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,0.95 [0.71-1.27],0.718766545453639,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.88 [0.44-1.77],0.719609730579772,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,APCS,Serum amyloid P-component,Inverse variance weighted,3,0.79 [0.21-2.93],0.724140503594069,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.83 [0.3-2.32],0.725112446191694,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.92 [0.56-1.5],0.730617546801989,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.45 [0.17-12.34],0.731841041478444,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRSS8,Prostasin,Inverse variance weighted,14,1.09 [0.66-1.81],0.732820327914146,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,XCL1,Lymphotactin,Inverse variance weighted,15,0.89 [0.47-1.71],0.733462761974171,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.94 [0.66-1.34],0.736404822450295,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.06 [0.73-1.54],0.739579054257737,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.39 [0.2-9.62],0.739717879589778,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.81 [0.23-2.81],0.740122066289408,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,0.92 [0.55-1.52],0.741435428848892,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,0.89 [0.46-1.75],0.741624065961308,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SNCG,Gamma-synuclein,Inverse variance weighted,47,1.03 [0.88-1.2],0.74306656071828,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.9 [0.47-1.73],0.746974533433958,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,0.92 [0.55-1.54],0.749555446861198,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.85 [0.3-2.39],0.755693870365491,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,POF1B,Protein POF1B,Inverse variance weighted,4,0.86 [0.34-2.19],0.756820361463421,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.89 [0.44-1.83],0.758529789504639,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.78 [0.16-3.8],0.759739070525039,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.75 [0.12-4.71],0.761262123885801,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.06 [0.73-1.52],0.761948572671682,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.18 [0.4-3.53],0.762870335651245,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PVR,Poliovirus receptor,Inverse variance weighted,3,0.8 [0.18-3.51],0.764451919168669,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.03 [0.84-1.26],0.764464565440067,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLK4,Kallikrein-4,Inverse variance weighted,5,1.27 [0.26-6.19],0.764746818837211,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.15 [0.45-2.93],0.766352814110394,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.11 [0.56-2.17],0.768296550491009,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,1.07 [0.69-1.66],0.769433873255708,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.76 [0.12-4.87],0.77175344324344,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,1.07 [0.68-1.69],0.77436726869608,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.23 [0.29-5.24],0.777173019894569,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.87 [0.3-2.48],0.789671891938768,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,1.03 [0.8-1.34],0.792812846866251,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.91 [0.45-1.85],0.799370981372927,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.08 [0.59-1.95],0.809241339061238,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.03 [0.81-1.31],0.810190956259277,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,0.88 [0.29-2.68],0.819450264568117,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,1.12 [0.41-3.07],0.820491593543853,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.25 [0.18-8.55],0.820582382678687,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.23 [0.19-7.78],0.825442199195363,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.06 [0.62-1.8],0.83175406168768,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.93 [0.5-1.75],0.832915736748506,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.18 [0.24-5.75],0.834068435249018,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.97 [0.76-1.24],0.837496093146496,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.97 [0.71-1.32],0.837761247722419,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.05 [0.62-1.78],0.842766256654951,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.18 [0.22-6.39],0.844248093823684,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.98 [0.84-1.16],0.852234306710462,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.09 [0.42-2.83],0.853165995050539,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.96 [0.61-1.51],0.857034387752854,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.07 [0.5-2.29],0.859340644452039,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,0.91 [0.3-2.75],0.861821535409344,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.96 [0.62-1.5],0.867436876218089,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.94 [0.43-2.05],0.868421761715442,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PENK,Proenkephalin-A,Inverse variance weighted,15,0.97 [0.64-1.46],0.869299221467187,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.94 [0.47-1.91],0.86979555928859,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.09 [0.39-3.08],0.870595528268498,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GRN,Progranulin,Inverse variance weighted,46,0.99 [0.82-1.18],0.871745407169872,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,GUCA2A,Guanylin,Inverse variance weighted,7,1.07 [0.47-2.4],0.872578164539516,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.02 [0.77-1.37],0.872608917666436,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FBLN2,Fibulin-2,Inverse variance weighted,6,1.09 [0.38-3.12],0.87274207780984,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.05 [0.59-1.86],0.874230264798623,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.2 [0.13-11.16],0.8746639983784,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.97 [0.63-1.49],0.879179426953801,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.16 [0.16-8.44],0.881681811258304,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EPO,Erythropoietin,Inverse variance weighted,11,0.97 [0.62-1.51],0.887399539323641,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.04 [0.57-1.89],0.896392501888843,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.03 [0.69-1.54],0.897238828236513,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,0.94 [0.33-2.64],0.899682470344239,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.93 [0.3-2.89],0.89994143097217,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,OCLN,Occludin,Inverse variance weighted,2,0.89 [0.13-5.94],0.90283860708984,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.97 [0.54-1.73],0.905227175376696,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,1.16 [0.1-13.38],0.905677668295976,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AOC3,Membrane primary amine oxidase,Inverse variance weighted,33,1.01 [0.83-1.24],0.907022721379409,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.9 [0.14-5.61],0.91129457705708,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.99 [0.84-1.17],0.911308043063144,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,AGRN,Agrin,Inverse variance weighted,14,0.97 [0.57-1.65],0.914286370862143,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.02 [0.68-1.54],0.917755757194442,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LAYN,Layilin,Inverse variance weighted,3,1.08 [0.23-5.02],0.921750671724645,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BGLAP,Osteocalcin,Inverse variance weighted,8,0.96 [0.41-2.24],0.925746171228915,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.96 [0.37-2.49],0.927708291551024,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHGB,Secretogranin-1,Inverse variance weighted,7,1.03 [0.53-2.01],0.935880757694732,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.06 [0.26-4.34],0.937485170745747,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.9 [0.07-12],0.938828952113985,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.98 [0.66-1.48],0.940066391550255,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CFP,Properdin,Inverse variance weighted,17,0.99 [0.68-1.43],0.943587262463335,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,0.98 [0.58-1.67],0.948836692485653,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1.01 [0.69-1.48],0.955112279870924,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,1.01 [0.64-1.61],0.958120180198098,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.39-2.43],0.959553455955256,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CCN3,CCN family member 3,Inverse variance weighted,17,0.99 [0.73-1.36],0.967087804852981,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.01 [0.52-1.97],0.968778744676045,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,MMP7,Matrilysin,Wald ratio,1,0.98 [0.37-2.6],0.970675632608847,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,BCAN,Brevican core protein,Inverse variance weighted,12,0.99 [0.5-1.95],0.972721278199845,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,1.02 [0.41-2.53],0.974289815861537,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,1.01 [0.71-1.43],0.975942698829536,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,0.99 [0.59-1.67],0.976188193567733,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,KLK11,Kallikrein-11,Inverse variance weighted,13,0.99 [0.58-1.69],0.978516330777663,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNC,Tenascin,Inverse variance weighted,57,1 [0.83-1.21],0.978610479142604,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.99 [0.32-3],0.980698397617621,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1 [0.78-1.27],0.983397579394885,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REN,Renin,Inverse variance weighted,8,0.99 [0.43-2.31],0.987780782858215,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1 [0.7-1.41],0.990319098705539,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.74-1.36],0.992367448012163,trans
Chapter IX Diseases of the circulatory system,I9_RHEUVALV,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1 [0.58-1.73],0.99900891619949,trans
